Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline IRS Q1 2026 Earnings Significant Loss Reported as Stock Declines SBEV Q2 2025 Earnings Significant EPS Miss Reflects Ongoing Challenges ARIS Q1 2026 Earnings Gold Producer Misses EPS Estimates Shares Dip PDCC Q4 2025 Earnings EPS Misses Estimates as Stock Declines Over 3 NOG Q1 2026 Earnings EPS Beats Estimates by 789